TTNP — Titan Pharmaceuticals Share News
0.000.00%
Titan Pharma up on reverse merger deal with air transport system developer
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
Brief: Titan Pharmaceuticals Inc. Announces Licensing Agreement With Ocular Therapeutix Inc.
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber
Titan Pharma gains on licensing agreement with Ocular Therapeutix
Brief: Update -- Titan Pharmaceuticals Announces Licensing Deal With Ocular Therapeutix
Brief: Titan Pharmaceuticals Announces Board Expansion And Management Changes
Brief: Titan Pharma Received Confirmation From Nasdaq That Co Has Regained Compliance
Brief: Titan Pharmaceuticals Received Request From Activist Investing Llc To Change Date For Special Meeting Of Stockholders To Aug. 15, 2022
Brief: Activist Investing Nominates Slate Of Director Candidates For Election To Board Of Titan Pharmaceuticals
Brief: David Lazar Says On July 8, Delivered Special Meeting Request Letter To Titan Pharmaceuticals' Board
U.S. STOCKS ON THE MOVE-Uber Technologies Inc, Titan Pharmaceuticals Inc, Lululemon Athletica Inc
Titan Pharma up as FDA clears opioid use disorder therapy study
Brief: Titan Pharmaceuticals Announces FDA Clearance Of IND Application For Nalmefene Implant
Brief: Activist Investing Discloses 9.9% Ownership Interest In Titan Pharmaceuticals
Brief: Titan Pharmaceuticals Says Co Implemented Plan To Reduce Expenses & Conserve Capital
Brief: Activist Investing Announces 5.6% Ownership Interest In Titan Pharmaceuticals, Inc.
Brief: Titan Pharmaceuticals Announces Pricing Of $5.5 Mln Registered Direct And Pipe Offering Priced At-The-Market
U.S. STOCKS ON THE MOVE-BlackBerry, Boeing, Mastercard, Banks, COVID-19 vaccine stocks